| Effect of glycyrrhizin on the activity of CYP3A enzyme in humans JH Tu, YJ He, Y Chen, L Fan, W Zhang, ZR Tan, YF Huang, D Guo, DL Hu, ... European journal of clinical pharmacology 66 (8), 805-810, 2010 | 353 | 2010 |
| The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers G Wang, HP Lei, Z Li, ZR Tan, D Guo, L Fan, Y Chen, DL Hu, D Wang, ... European journal of clinical pharmacology 65, 281-285, 2009 | 191 | 2009 |
| The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion‐transporting polypeptide 1B1 L Fan, W Zhang, D Guo, ZR Tan, P Xu, Q Li, YZ Liu, L Zhang, TY He, ... Clinical Pharmacology & Therapeutics 83 (3), 471-476, 2008 | 131 | 2008 |
| Metformin induces osteoblastic differentiation of human induced pluripotent stem cell‐derived mesenchymal stem cells P Wang, T Ma, D Guo, K Hu, Y Shu, HHK Xu, A Schneider Journal of tissue engineering and regenerative medicine 12 (2), 437-446, 2018 | 93 | 2018 |
| Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T> C polymorphism YJ He, W Zhang, Y Chen, D Guo, JH Tu, LY Xu, ZR Tan, BL Chen, Z Li, ... Clinica Chimica Acta 405 (1-2), 49-52, 2009 | 92 | 2009 |
| Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs) Q Li, D Guo, Z Dong, W Zhang, L Zhang, SM Huang, JE Polli, Y Shu Toxicology and applied pharmacology 273 (1), 100-109, 2013 | 88 | 2013 |
| Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers Y Han, D Guo, Y Chen, Y Chen, ZR Tan, HH Zhou European journal of clinical pharmacology 65, 585-591, 2009 | 85 | 2009 |
| SIMULTANEOUS ACTION OF THE FLAVONOID QUERCETIN ON CYTOCHROME P450 (CYP) 1A2, CYP2A6, N‐ACETYLTRANSFERASE AND XANTHINE … Y Chen, P Xiao, DS Ou‐Yang, L Fan, D Guo, YN Wang, Y Han, JH Tu, ... Clinical and Experimental Pharmacology and Physiology 36 (8), 828-833, 2009 | 76 | 2009 |
| Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes Y Li, W Zhang, D Guo, G Zhou, H Zhou, Z Xiao Clinica Chimica Acta 391 (1-2), 60-67, 2008 | 60 | 2008 |
| Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers Y Han, D Guo, Y Chen, ZR Tan, HH Zhou Xenobiotica 39 (9), 694-699, 2009 | 53 | 2009 |
| Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertension JQ Luo, FZ He, ZY Luo, JG Wen, LY Wang, NL Sun, GF Tang, Q Li, D Guo, ... Pharmacogenetics and genomics 24 (6), 306-313, 2014 | 47 | 2014 |
| Aging increases the susceptibility of cisplatin-induced nephrotoxicity J Wen, M Zeng, Y Shu, D Guo, Y Sun, Z Guo, Y Wang, Z Liu, H Zhou, ... Age 37, 1-13, 2015 | 42 | 2015 |
| Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis Z Ye, Q Li, Q Guo, Y Xiong, D Guo, H Yang, Y Shu Neuropharmacology 128, 63-75, 2018 | 41 | 2018 |
| Novel calcium phosphate cement with metformin-loaded chitosan for odontogenic differentiation of human dental pulp cells W Qin, JY Chen, J Guo, T Ma, MD Weir, D Guo, Y Shu, ZM Lin, ... Stem Cells International 2018, 2018 | 38 | 2018 |
| Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers D Guo, LF Pang, Y Han, H Yang, G Wang, Z Tan, W Zhang, HH Zhou European journal of clinical pharmacology 69, 843-849, 2013 | 38 | 2013 |
| Hepatic nuclear factor 1α inhibitor ursodeoxycholic acid influences pharmacokinetics of the organic anion transporting polypeptide 1B1 substrate rosuvastatin and bilirubin YJ He, W Zhang, JH Tu, J Kirchheiner, Y Chen, D Guo, Q Li, ZY Li, ... Drug metabolism and disposition 36 (8), 1453-1456, 2008 | 31 | 2008 |
| Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes LJ Yang, L Fan, ZQ Liu, YM Mao, D Guo, LH Liu, ZR Tan, L Peng, CT Han, ... European journal of clinical pharmacology 65, 601-608, 2009 | 29 | 2009 |
| Selective inhibition on organic cation transporters by carvedilol protects mice from cisplatin-induced nephrotoxicity D Guo, H Yang, Q Li, HJ Bae, O Obianom, S Zeng, T Su, JE Polli, Y Shu Pharmaceutical research 35, 1-10, 2018 | 27 | 2018 |
| Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2) P Zhu, Z Ye, D Guo, Z Xiong, S Huang, J Guo, W Zhang, JE Polli, H Zhou, ... Pharmaceutical research 35, 1-10, 2018 | 26 | 2018 |
| Pyrazole-4-Carboxamide (YW2065): A therapeutic candidate for colorectal cancer via dual activities of Wnt/β-catenin signaling inhibition and AMP-activated protein kinase (AMPK … W Yang, Y Li, Y Ai, ON Obianom, D Guo, H Yang, S Sakamuru, M Xia, ... Journal of medicinal chemistry 62 (24), 11151-11164, 2019 | 25 | 2019 |
